
From Asia to Paris: Three Runners Supporting a UK Charity with Global Impact
Three runners from Hong Kong and Singapore are traveling to Paris in April 2025 to raise funds for Cure Leukaemia, highlighting the global impact of blood cancer research.
Chronic Myeloid Leukaemia (CML) is a form of leukaemia where you have an increase in your white blood cells.
In CML, your bone marrow (the spongey part inside your bones) is producing too many myeloid cells, which are underdeveloped white blood cells that don’t work properly.
CML often develops slowly over several years, and is most common in people aged between 60 – 65.
Roughly, CML makes up 15 out of 100 leukaemia cases.
The majority of CML patients are asymptomatic, meaning little to no symptoms, and CML is only picked up through a blood test from their GP.
For some, where they have a much higher count of white blood cells, some patients experience:
– pain from an enlarged spleen
– Anemia
– Tiredness
– Bone pains
Treatment depends on if you’re asymptomatic or have a very high white blood cell count.
If you have a very high blood count, you could be put on a special machine that helps to skim off some of the extra white blood cells.
You could also be given medication to control and bring the white blood cell count down.
Three runners from Hong Kong and Singapore are traveling to Paris in April 2025 to raise funds for Cure Leukaemia, highlighting the global impact of blood cancer research.
Our Paris Marathon 2025 team is growing, including one runner who has battled the disease himself.
We’re now working with Run For Charity, a platform that enables individuals to take part in fundraising events supporting blood cancer patients across the UK.
Every year, 4th February marks World Cancer Day, a global initiative to raise awareness, improve education, and drive action for a world without cancer.